Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis. (2023)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(22)00475-2
PubMed Identifier: 36521952
Publication URI: http://europepmc.org/abstract/MED/36521952
Type: Journal Article/Review
Volume: 11
Parent Publication: The Lancet. Global health
Issue: 1
ISSN: 2214-109X